Free Trial

Medtronic (MDT) Competitors

$81.50
-0.50 (-0.61%)
(As of 05/29/2024 ET)

MDT vs. ABT, ISRG, SYK, BSX, BDX, EW, DXCM, IDXX, RMD, and STE

Should you be buying Medtronic stock or one of its competitors? The main competitors of Medtronic include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), and STERIS (STE). These companies are all part of the "health care equipment" industry.

Medtronic vs.

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation, community ranking and risk.

Abbott Laboratories has higher revenue and earnings than Medtronic. Medtronic is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abbott Laboratories$40.11B4.37$5.72B$3.2131.38
Medtronic$32.36B3.34$3.68B$2.7529.64

Abbott Laboratories currently has a consensus target price of $120.60, indicating a potential upside of 19.71%. Medtronic has a consensus target price of $94.00, indicating a potential upside of 15.34%. Given Medtronic's stronger consensus rating and higher possible upside, analysts plainly believe Abbott Laboratories is more favorable than Medtronic.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abbott Laboratories
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.67
Medtronic
1 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.36

In the previous week, Medtronic had 54 more articles in the media than Abbott Laboratories. MarketBeat recorded 74 mentions for Medtronic and 20 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 0.75 beat Medtronic's score of 0.61 indicating that Medtronic is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Abbott Laboratories
11 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Medtronic
29 Very Positive mention(s)
12 Positive mention(s)
19 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Medtronic received 660 more outperform votes than Abbott Laboratories when rated by MarketBeat users. Likewise, 76.39% of users gave Medtronic an outperform vote while only 69.62% of users gave Abbott Laboratories an outperform vote.

CompanyUnderperformOutperform
Abbott LaboratoriesOutperform Votes
919
69.62%
Underperform Votes
401
30.38%
MedtronicOutperform Votes
1579
76.39%
Underperform Votes
488
23.61%

Abbott Laboratories has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

Abbott Laboratories has a net margin of 13.96% compared to Abbott Laboratories' net margin of 11.36%. Medtronic's return on equity of 20.18% beat Abbott Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
Abbott Laboratories13.96% 20.18% 10.60%
Medtronic 11.36%13.47%7.65%

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 82.1% of Medtronic shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.3% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Abbott Laboratories pays an annual dividend of $2.20 per share and has a dividend yield of 2.2%. Medtronic pays an annual dividend of $2.76 per share and has a dividend yield of 3.4%. Abbott Laboratories pays out 68.5% of its earnings in the form of a dividend. Medtronic pays out 100.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories has increased its dividend for 53 consecutive years and Medtronic has increased its dividend for 47 consecutive years.

Summary

Abbott Laboratories beats Medtronic on 14 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDT vs. The Competition

MetricMedtronicElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$108.22B$3.22B$5.12B$17.46B
Dividend Yield3.35%1.68%2.83%3.53%
P/E Ratio29.649.69170.8425.51
Price / Sales3.3470.282,441.8210.12
Price / Cash11.4274.8735.2719.29
Price / Book2.154.335.515.82
Net Income$3.68B$87.88M$105.57M$975.72M
7 Day Performance0.15%-1.27%-0.90%-1.95%
1 Month Performance1.56%12.93%2.20%1.12%
1 Year Performance-1.22%-4.31%5.02%21.80%

Medtronic Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABT
Abbott Laboratories
4.9542 of 5 stars
$101.35
-0.6%
$120.60
+19.0%
-2.1%$176.31B$40.11B31.57114,000News Coverage
Positive News
ISRG
Intuitive Surgical
4.4299 of 5 stars
$399.42
-0.4%
$396.17
-0.8%
+29.8%$141.67B$7.12B72.1013,676Short Interest ↑
SYK
Stryker
4.8137 of 5 stars
$339.34
+1.1%
$370.50
+9.2%
+25.1%$129.27B$20.50B38.7452,000
BSX
Boston Scientific
4.5584 of 5 stars
$75.17
-0.6%
$76.09
+1.2%
+46.8%$110.28B$14.24B63.1748,000Analyst Forecast
Insider Selling
Short Interest ↓
News Coverage
BDX
Becton, Dickinson and Company
4.9743 of 5 stars
$226.85
-0.8%
$281.40
+24.0%
-6.7%$65.56B$19.37B49.9773,000Short Interest ↓
Analyst Revision
EW
Edwards Lifesciences
4.747 of 5 stars
$87.04
-1.1%
$94.31
+8.4%
+6.2%$52.45B$6.00B37.5219,800Short Interest ↓
DXCM
DexCom
4.9518 of 5 stars
$127.38
+0.0%
$141.67
+11.2%
+10.9%$50.66B$3.62B82.189,600Short Interest ↓
Positive News
IDXX
IDEXX Laboratories
4.3407 of 5 stars
$505.40
-2.1%
$580.38
+14.8%
+6.3%$41.74B$3.66B48.9311,000Positive News
RMD
ResMed
4.5431 of 5 stars
$207.17
-2.9%
$202.80
-2.1%
-4.4%$30.44B$4.22B31.8210,140Analyst Revision
Positive News
STE
STERIS
4.0437 of 5 stars
$223.39
-2.5%
$241.60
+8.2%
+11.5%$22.07B$5.14B58.4817,100Positive News

Related Companies and Tools

This page (NYSE:MDT) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners